# ZBTB49

## Overview
ZBTB49 is a gene that encodes the zinc finger and BTB domain-containing protein 49, which is part of a family of transcriptional regulators known for their roles in gene expression modulation. The protein is characterized by its zinc finger motifs, which facilitate DNA binding, and a BTB domain that enables protein-protein interactions, categorizing it as a transcriptional regulator. ZBTB49 is primarily active in the nucleus, where it participates in chromatin remodeling and transcriptional repression, influencing various cellular processes (Jen2016Zinc). The gene has been implicated in cancer biology, with potential tumor suppressor functions and involvement in pathways related to cell cycle regulation and apoptosis (Liu2022Linkage). Additionally, ZBTB49 is associated with the TGF-β signaling pathway, highlighting its broader role in cellular homeostasis and disease (Ong2017Identification).

## Structure


## Function
ZBTB49 is a gene encoding a protein that is part of the zinc finger and BTB domain family, which typically functions as transcriptional regulators. These proteins influence gene expression by binding to DNA, playing a role in chromatin remodeling and transcriptional repression. ZBTB49 is active in the nucleus, where it is involved in various cellular processes (Jen2016Zinc).

In the context of cancer research, ZBTB49 has been suggested to have a tumor suppressor function. It may be involved in pathways related to tumor suppression, potentially being induced by TP53 or inducing RB1, which are critical in regulating cell cycle and apoptosis (Liu2022Linkage). Although specific high-risk genes were not identified in studies, ZBTB49, along with TAF3, was suggested as a potential low-risk gene associated with colorectal cancer, indicating its possible role in genetic predisposition to cancer (Liu2022Linkage).

Additionally, ZBTB49 has been identified as a target gene modulated by TGF-β1-induced miRNAs, such as miR-21-3p, in primary lung fibroblasts. This suggests its involvement in the TGF-β signaling pathway, which is crucial for various cellular processes, including ECM homeostasis (Ong2017Identification).

## Clinical Significance
The ZBTB49 gene has been implicated in various diseases, particularly in the context of cancer. In silent corticotroph tumors (SCTs), ZBTB49 is upregulated and is thought to play a role in the transcriptional reprogramming that contributes to the invasive behavior of these tumors. This upregulation is associated with features of epithelial-to-mesenchymal transition (EMT), which is linked to increased tumor invasiveness (Zhang2022Single-cell).

In anaplastic thyroid carcinoma (ATC), ZBTB49 is identified as one of the transcription factors involved in the regulation of ATC-specific genes. The study highlights its potential role in the transcriptional network that contributes to the aggressive nature of ATC, although specific clinical implications of ZBTB49 mutations or expression changes in ATC are not detailed (Weinberger2017Cell).

While these studies suggest a role for ZBTB49 in cancer, the precise clinical significance of mutations or alterations in its expression remains to be fully elucidated. Further research is needed to understand the potential of ZBTB49 as a therapeutic target or biomarker in these and other conditions.

## Interactions
ZBTB49 is a protein that participates in various interactions, primarily through its BTB domain, which is known for facilitating protein-protein interactions. ZBTB49 can form heterodimers with other BTB domain-containing proteins, such as MIZ1. This interaction is significant because it can reduce MIZ1-dependent transcription of CDKN1A, a gene involved in cell cycle regulation (Orth2021Identification).

In the context of colorectal cancer (CRC), ZBTB49 has been identified as a potential marker for FOLFOX chemotherapy resistance. It is highly expressed in normal epithelial cells but repressed in tumor tissues. ZBTB49 expression is induced by p53 in response to DNA damage, leading to cancer cell cycle arrest. This suggests that ZBTB49 may play a role in the cellular response to DNA damage and could be involved in regulatory pathways that influence cancer progression and treatment response (Kryczka2024Stepbystep).

While specific interactions of ZBTB49 with nucleic acids or other proteins beyond MIZ1 are not detailed in the provided context, its involvement in transcriptional regulation and response to DNA damage indicates its potential role in complex cellular processes.


## References


[1. (Ong2017Identification) Jennie Ong, Wim Timens, Vijay Rajendran, Arjan Algra, Avrum Spira, Marc E. Lenburg, Joshua D. Campbell, Maarten van den Berge, Dirkje S. Postma, Anke van den Berg, Joost Kluiver, and Corry-Anke Brandsma. Identification of transforming growth factor-beta-regulated micrornas and the microrna-targetomes in primary lung fibroblasts. PLOS ONE, 12(9):e0183815, September 2017. URL: http://dx.doi.org/10.1371/journal.pone.0183815, doi:10.1371/journal.pone.0183815. This article has 36 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0183815)

[2. (Liu2022Linkage) Wen Liu, Mark Gonn, Susanna Holst, Jessada Thutkawkorapin, Xiang Jiao, Jan Björk2, Ann-Sofie Backman, Kristina Lagerstedt-Robinson, and Annika Lindblom. Linkage and association analysis define novel regions for the risk of adenomas and colorectal cancer. Medical Research Archives, 2022. URL: http://dx.doi.org/10.18103/mra.v10i4.2780, doi:10.18103/mra.v10i4.2780. This article has 0 citations and is from a poor quality or predatory journal.](https://doi.org/10.18103/mra.v10i4.2780)

[3. (Orth2021Identification) Barbara Orth, Bodo Sander, Andreas Möglich, Kay Diederichs, Martin Eilers, and Sonja Lorenz. Identification of an atypical interaction site in the btb domain of the myc-interacting zinc-finger protein 1. Structure, 29(11):1230-1240.e5, November 2021. URL: http://dx.doi.org/10.1016/j.str.2021.06.005, doi:10.1016/j.str.2021.06.005. This article has 10 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.str.2021.06.005)

[4. (Jen2016Zinc) Jayu Jen and Yi-Ching Wang. Zinc finger proteins in cancer progression. Journal of Biomedical Science, July 2016. URL: http://dx.doi.org/10.1186/s12929-016-0269-9, doi:10.1186/s12929-016-0269-9. This article has 249 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s12929-016-0269-9)

[5. (Weinberger2017Cell) Paul Weinberger, Sithara Raju Ponny, Hongyan Xu, Shan Bai, Robert Smallridge, John Copland, and Ashok Sharma. Cell cycle m-phase genes are highly upregulated in anaplastic thyroid carcinoma. Thyroid, 27(2):236–252, February 2017. URL: http://dx.doi.org/10.1089/thy.2016.0285, doi:10.1089/thy.2016.0285. This article has 44 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/thy.2016.0285)

6. (Kryczka2024Stepbystep) Step-by-step Elimination Algorithm Based on Modified Radial Data Visualization to Predict the Response to FOLFOX Treatment of CRC Patients. This article has 0 citations.

[7. (Zhang2022Single-cell) Dongyun Zhang, Willy Hugo, Marvin Bergsneider, Marilene B Wang, Won Kim, Harry V Vinters, and Anthony P Heaney. Single-cell rna sequencing in silent corticotroph tumors confirms impaired pomc processing and provides new insights into their invasive behavior. European Journal of Endocrinology, 187(1):49–64, May 2022. URL: http://dx.doi.org/10.1530/eje-21-1183, doi:10.1530/eje-21-1183. This article has 16 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1530/eje-21-1183)